Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction


TARTAN Z., OZER N., UYAREL H., AKGUL O., GUL M., Cetin M., ...More

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, vol.18, no.6, pp.441-447, 2008 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2008
  • Doi Number: 10.1016/j.numecd.2007.02.015
  • Journal Name: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.441-447
  • Keywords: metabolic syndrome, no-reflow phenomenon, ST-segment, resolution, primary coronary intervention, CORONARY-ARTERY OCCLUSION, INSULIN-RESISTANCE, REPERFUSION, RESOLUTION, FLOW, ANGIOPLASTY, DYSFUNCTION, PERFUSION, PLATELET, ABNORMALITIES

Abstract

background and aim: The purpose of this study was to evaluate both the predictive value of metabolic syndrome (MS) on no-reflow phenomenon and 30-day clinical outcomes on patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infaction (STEMI).